Document:

NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

BARFRESH
FOOD GROUP Inc.

 

PLACEMENT
AGENT WARRANT TO PURCHASE COMMON STOCK

 

	Warrant
    No. PA-	 	 
	 	 	 
	Number
    of Placement Agent Warrants 132,520	 	Issuance
    Date: ________________

 

Barfresh
Food Group Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, _____________, the registered holder hereof or its permitted
assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at
the Exercise Price (as defined below) then in effect, upon exercise of this Placement Agent Warrant to Purchase Common Stock (including
any Placement Agent Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”),
at any time or times on or after the Issuance Date set forth above (“Issuance Date”), but not after 11:59 p.m.,
New York time, on the Expiration Date (as defined below), ____________ (subject to adjustment as provided herein) fully
paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”).

 

This
Warrant is issued pursuant to that certain Placement Agent’s Agreement, dated May 6, 2013 by and among the Company and the
Holder (the “Placement Agent’s Agreement”). Except as otherwise defined herein, capitalized terms in
this Warrant shall have the meanings set forth in that certain Subscription Agreement entered into by the investor in the private
placement which terminated on August 7, 2013.

 

    	1

    	 

    

  

1.
Exercise of Warrant.

 

(a)
Mechanics of Exercise.

 

(i)
Subject to the terms and conditions hereof (including, without limitation,
the limitations set forth in Section 1(e)), the purchase rights represented by this Warrant are exercisable by the Holder
in whole or in part at any time, or from time to time, by the surrender of this Warrant and the Notice of Exercise annexed hereto
as Exhibit A duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or
agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books
of the Company), upon payment (i) in cash or by check acceptable to the Company, or (ii) by cashless exercise as set forth in
Section 1(a)(ii), below, of the purchase price of the shares to be purchased.

 

(ii)
This Warrant shall be deemed to have been exercised immediately
prior to the close of business on the date of its surrender for exercise as provided above and payment of the Exercise Price if
exercised for cash, and the person entitled to receive the shares of Common Stock issuable upon such exercise shall be treated
for all purposes as the holder of record of such shares as of the close of business on such date (the “Exercise Date”).
As promptly as practicable on or after the Exercise Date, but in no event more than three (3) business days thereafter (the “Warrant
Share Delivery Date”), the Company at its expense shall issue and deliver to the person or persons entitled to receive
the same a certificate or certificates for the number of shares issuable upon such exercise. In the event that this Warrant is
exercised in part, the Company at its expense will execute and deliver a new Warrant of like tenor exercisable for the number
of shares for which this Warrant may then be exercised.

 

(iii)
The Holder, at its option, may exercise this Warrant in a cashless
exercise transaction pursuant to this subsection (c) (a “Cashless Exercise”). In order to effect a Cashless Exercise,
the Holder shall surrender this Warrant at the principal office of the Company together with an Exercise Form, completed and executed,
indicating Holder’s election to effect a Cashless Exercise, in which event the Company shall issue Holder a number of shares
of Common Stock computed using the following formula:

 

    	2

    	 

    

  

X
= Y (A-B)/A

 

where:
X = the number of shares of Common Stock to be issued to Holder.

 

Y
= the number of shares of Common Stock for which this Warrant is being Exercised.

 

A
= the Market Price of one (1) share of Common Stock (for purposes of this Section 1(c), where “Market Price,” means
the Volume Weighted Average Price (as defined herein) of one (1) share of Common Stock during the ten (10) consecutive Trading
Day period immediately preceding the Exercise Date.

 

B
= the Exercise Price.

 

As
used herein, the “Volume Weighted Average Price” for any security as of any date means the volume weighted average
sale price on The NASDAQ Global Market (“NASDAQ”) as reported by, or based upon data reported by, Bloomberg Financial
Markets or an equivalent, reliable reporting service mutually acceptable to and hereafter designated by holders of a majority
in interest of the Warrants and the Company (“Bloomberg”) or, if NASDAQ is not the principal trading market for such
security, the volume weighted average sale price of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or, if no volume weighted average sale price is reported for such
security, then the last closing trade price of such security as reported by Bloomberg, or, if no last closing trade price is reported
for such security by Bloomberg, the average of the bid prices of any market makers for such security that are listed in the over
the counter market by the Financial Industry Regulatory Authority, Inc. or in the “pink sheets” by the Pink OTC Market,
Inc. If the Volume Weighted Average Price cannot be calculated for such security on such date in the manner provided above, the
volume weighted average price shall be the fair market value as determined in good faith by the Company’s Board of Directors.
“Trading Day” shall mean any day on which the Common Stock is traded for any period on NASDAQ, or on the principal
securities exchange or other securities market on which the Common Stock is then being traded.

 

For
purposes of Rule 144 and sub-section (d)(3)(ii) thereof, it is intended, understood and acknowledged that the Common Stock issued
upon Exercise of this Warrant in a Cashless Exercise transaction shall be deemed to have been acquired at the time this Warrant
was issued. Moreover, it is intended, understood and acknowledged that the holding period for the Common Stock issued upon Exercise
of this Warrant in a Cashless Exercise transaction shall be deemed to have commenced on the date this Warrant was issued.

 

In
the case of a dispute as to the determination of the closing price or the Volume Weighted Average Price of the Company’s
Common Stock or the arithmetic calculation of the Exercise Price or Market Price, the Company shall submit the disputed determinations
or arithmetic calculations via facsimile within four (4) business days of receipt, or deemed receipt, of the Exercise Notice,
or other event giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree
upon such determination or calculation within two (2) business days of such disputed determination or arithmetic calculation being
submitted to the Holder, then the Company shall, within two (2) business days submit via facsimile (i) the disputed determination
of the closing price or the Volume Weighted Average Price of the Company’s Common Stock to an independent, reputable investment
bank selected by the Company and approved by the Holder, which approval shall not be unreasonably withheld or delayed or (ii)
the disputed arithmetic calculation of the Exercise Price, Market Price to the Company’s independent, outside accountant,
or another accounting firm of national standing selected by the Company. The Company shall cause the investment bank or the accountant,
as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later
than the later of (i) five (5) business days from the time it receives the disputed determinations or calculations or (ii) five
(5) business days from the selection of the investment bank and accounting firm, as applicable. Such investment bank’s or
accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

    	3

    	 

    

  

(b)
Exercise Price. For purposes of this Warrant, “Exercise
Price” means $0.25, subject to adjustment as provided herein.

 

(c)
Company’s Failure to Timely Deliver Securities. If the Company
shall fail, for any reason or for no reason, to issue to the Holder within the later of (i) three (3) Trading Days after receipt
of the applicable Exercise Notice (or four (4) Trading Days if the Exercise Notice is delivered after 5:00 P.M., New York City
time, on the Exercise Date) and (ii) two (2) Trading Days after the Company’s receipt of the Aggregate Exercise Price (or
three (3) Trading Days if the Company receives the Aggregate Exercise Price after 5:00 P.M., New York City time, on the Exercise
Date) (such later date, the “Share Delivery Deadline”), a certificate for the number of shares of Common Stock
to which the Holder is entitled and register such shares of Common Stock on the Company’s share register or to credit the
Holder’s balance account with DTC for such number of shares of Common Stock to which the Holder is entitled upon the Holder’s
exercise of this Warrant (as the case may be), and if after such Share Delivery Deadline the Holder purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the
number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock, issuable upon such exercise that the Holder so anticipated receiving from the Company, then, in addition
to all other remedies available to the Holder, the Company shall, within three (3) Business Days after the Holder’s request
and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase
price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including,
without limitation, by any other Person in respect, or on behalf, of the Holder) (the “Buy-In Price”), at which
point the Company’s obligation to so issue and deliver such certificate or credit the Holder’s balance account with
DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise hereunder (as the
case may be) (and to issue such shares of Common Stock) shall terminate, or (ii) promptly honor its obligation to so issue and
deliver to the Holder a certificate or certificates representing such shares of Common Stock or credit the Holder’s balance
account with DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise hereunder
(as the case may be) and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product
of (A) such number of shares of Common Stock multiplied by (B) the lowest Closing Sale Price of the Common Stock on any Trading
Day during the period commencing on the date of the applicable Exercise Notice and ending on the date of such issuance and payment
under this clause (ii).

 

    	4

    	 

    

  

(d)
Disputes. In the case of a dispute as to the determination of the
Exercise Price or the arithmetic calculation of the number of Warrant Shares to be issued pursuant to the terms hereof, the Company
shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with
Section 12.

 

(e)
Limitations on Exercises. Notwithstanding anything to the contrary
contained in this Warrant, this Warrant shall not be exercisable by the Holder hereof to the extent (but only to the extent) that
the Holder together with any of its affiliates would beneficially own in excess of 9.99% (the “Maximum Percentage”)
of the Common Stock after giving effect to such exercise and as a result of such exercise. To the extent the above limitation
applies, the determination of whether this Warrant shall be exercisable (vis-à-vis other convertible, exercisable or exchangeable
securities owned by the Holder or any of its affiliates) and of which such securities shall be exercisable (as among all such
securities owned by the Holder) shall, subject to such Maximum Percentage limitation, be determined on the basis of the first
submission to the Company for conversion, exercise or exchange (as the case may be). No prior inability to exercise this Warrant
pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any
subsequent determination of exercisability. For the purposes of this paragraph, beneficial ownership and all determinations and
calculations (including, without limitation, with respect to calculations of percentage ownership) shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. The provisions of this paragraph
shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage beneficial ownership limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum Percentage limitation.
The limitations contained in this paragraph shall apply to a successor Holder of this Warrant. For any reason at any time, upon
the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing to the
Holder the number of shares of Common Stock then outstanding, including by virtue of any prior conversion or exercise of convertible
or exercisable securities into Common Stock, including, without limitation, pursuant to this Warrant or securities issued pursuant
to the Placement Agent’s Agreement. By written notice to the Company, any Holder may increase or decrease the Maximum Percentage
to any other percentage specified in such notice; provided that (i) any such increase will not be effective until the 61st day
after such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder sending such
notice and not to any other holder of the Warrants. At any time when this Warrant, in its entirety or a portion thereof, is not
exercisable by Holder in accordance with the Maximum Percentage limitation described above, Holder may not assign or otherwise
transfer this Warrant in its entirety (in the event that the entirety of the Warrant is not exercisable as described) or the portion
of this Warrant that is not exercisable as described (in the event that a portion of this Warrant is not exercisable as described).

 

    	5

    	 

    

  

(f)
Insufficient Authorized Shares. The Company shall at all times keep
reserved for issuance under this Warrant a number of shares of Common Stock as shall be necessary to satisfy the Company’s
obligation to issue shares of Common Stock hereunder (without regard to any limitation otherwise contained herein with respect
to the number of shares of Common Stock that may be acquirable upon exercise of this Warrant). If, notwithstanding the foregoing,
and not in limitation thereof, at any time while any of the Warrants remain outstanding the Company does not have a sufficient
number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of
the Warrants at least a number of shares of Common Stock equal to the number of shares of Common Stock as shall from time to time
be necessary to effect the exercise of all of the Warrants then outstanding (the “Required Reserve Amount”)
(an “Authorized Share Failure”), then the Company shall promptly take all action necessary to increase the
Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve
Amount for all the Warrants then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable
after the date of the occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence
of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the
number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each stockholder with
a proxy statement or information statement and shall use its commercially reasonable efforts to solicit its stockholders’
approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders
that they approve such proposal.

 

Adjustment
of Exercise Price and Number of Warrant Shares. (a) If the Company, at any time on or after the Issuance Date, (i) pays a
stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution on any
class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization
or otherwise) one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines
(by combination, reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller
number of shares, then in each such case the Exercise Price shall be multiplied by a fraction (the “Adjustment Metric”)
of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the
denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of Warrant Shares
shall be divided by the Adjustment Metric. Any adjustment made pursuant to clause (i) of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and
any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date
of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during the period that an
Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted appropriately to reflect
such event.

 

    	6

    	 

    

  

2.
Noncircumvention. The Company hereby covenants and agrees
that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of
assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith
carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without
limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable
upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon
the exercise of this Warrant, and (iii) shall, so long as any of the Warrants are outstanding, take all action necessary to reserve
and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise
of the Warrants, the maximum number of shares of Common Stock as shall from time to time be necessary to effect the exercise of
the Warrants then outstanding (without regard to any limitations on exercise).

 

3.
Holder Not Deemed a Stockholder. Except as otherwise specifically
provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends
or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed
to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company
or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights,
or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise
of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to
purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities
are asserted by the Company or by creditors of the Company.

 

4.
Reissuance of Warrants.

 

(a)
Transfer of Warrant. If this Warrant is to be transferred, the Holder
shall surrender this Warrant to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder
a new Warrant (in accordance with Section 4(d)), registered as the Holder may request, representing the right to purchase the
number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying
this Warrant is being transferred, a new Warrant (in accordance with Section 4(d)) to the Holder representing the right to purchase
the number of Warrant Shares not being transferred.

 

    	7

    	 

    

  

(b)
Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant (as to which a written
certification and the indemnification contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction,
of any indemnification undertaking by the Holder to the Company in customary and reasonable form and, in the case of mutilation,
upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance
with Section 4(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

 

(c)
Exchangeable for Multiple Warrants. This Warrant is exchangeable,
upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with
Section 4(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and
each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated by the Holder
at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be given.

 

(d)
Issuance of New Warrants. Whenever the Company is required to issue
a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall
represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant
(or in the case of a new Warrant being issued pursuant to Section 4(a) or Section 4(c), the Warrant Shares designated by the Holder
which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance,
does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on
the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this
Warrant.

 

5.
Amendment and Waiver. Except as otherwise provided herein,
the provisions of this Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act
herein required to be performed by it, only if the Company has obtained the written consent of the Holder. The Holder shall be
entitled, at its option, to the benefit of any amendment of any other similar warrant
issued under the Placement Agent’s Agreement. No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party.

 

    	8

    	 

    

  

6.
Severability. If any provision of this Warrant is prohibited
by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise
be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable,
and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Warrant
so long as this Warrant as so modified continues to express, without material change, the original intentions of the parties as
to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not
substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the
prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to
that of the prohibited, invalid or unenforceable provision(s).

 

7.
Governing Law. This Warrant shall be governed by and construed
and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this
Warrant shall be governed by, the internal laws of the State of Delaware without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of Delaware. Each of the Parties submits to the jurisdiction of any state or federal
court sitting in the State of Delaware, in any action or proceeding arising out of or relating to this Agreement and agrees that
all claims in respect of the action or proceeding may be heard and determined in any such court. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed
or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company’s obligations to the Holder or to enforce a judgment or other court ruling in favor of the Holder.
THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF
ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

8.
Construction; Headings. This Warrant shall be deemed to be
jointly drafted by the Company and the Holder and shall not be construed against any Person as the drafter hereof. The headings
of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

 

    	9

    	 

    

  

9.
Dispute Resolution. In the case of a dispute as to the determination
of the Exercise Price, the Closing Sale Price, the Bid Price or fair market value or the arithmetic calculation of the Warrant
Shares (as the case may be), the Company or the Holder (as the case may be) shall submit the disputed determinations or arithmetic
calculations (as the case may be) via facsimile (i) within two (2) Business Days after receipt of the applicable notice giving
rise to such dispute to the Company or the Holder (as the case may be) or (ii) if no notice gave rise to such dispute, at any
time after the Holder learned of the circumstances giving rise to such dispute. If the Holder and the Company are unable to agree
upon such determination or calculation (as the case may be) of the Exercise Price, the Closing Sale Price, the Bid Price or fair
market value or the number of Warrant Shares (as the case may be) within three (3) Business Days of such disputed determination
or arithmetic calculation being submitted to the Company or the Holder (as the case may be), then the Company shall, within two
(2) Business Days submit via facsimile (a) the disputed determination of the Exercise Price, the Closing Sale Price, the Bid Price
or fair market value (as the case may be) to an independent, reputable investment bank selected by the Holder or (b) the disputed
arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant. The Company shall cause at
its expense the investment bank or the accountant (as the case may be) to perform the determinations or calculations (as the case
may be) and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives such
disputed determinations or calculations (as the case may be). Such investment bank’s or accountant’s determination
or calculation (as the case may be) shall be binding upon all parties absent demonstrable error. With regard to any conflict of
methods for dispute resolution as described in this paragraph compared to methods described in 1(a)(iii) above, the latter shall
prevail and be the applicable method in that circumstance.

 

10.
Remedies, Characterization, Other Obligations, Breaches and Injunctive
Relief. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this
Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply
with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument
other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the
like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided
herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may
be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant
shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity
of showing economic loss and without any bond or other security being required. The Company shall provide all information and
documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with
the terms and conditions of this Warrant (including, without limitation, compliance with Section 2 hereof). The issuance
of shares and certificates for shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to
the Holder or such shares for any issuance tax or other costs in respect thereof, provided that the Company shall not be required
to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name
other than the Holder or its agent on its behalf.

 

11.
Transfer. This Warrant may be offered for sale, sold, transferred
or assigned without the consent of the Company, except as may otherwise be required by the Placement Agent’s Agreement.

 

    	10

    	 

    

  

12.
Certain Definitions. For purposes of this Warrant, the following
terms shall have the following meanings:

 

(a)
“Common Stock” means the common stock, $0.000001
par value per share, of the Company.

 

(b)
“Convertible Securities” means any stock or other
security (other than Options) that is at any time and under any circumstances, directly or indirectly, convertible into, exercisable
or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares of Common Stock.

 

(c)
“Expiration Date” means the date that is the
three (3) year anniversary of the Issuance Date or, if such date falls on a day other than a Business Day or on which trading
does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(d)
“Options” means any rights, warrants or options
to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(e)
“Per Share Market Value” means on any particular
date (a) the last closing bid price per share of the Common Stock on such date on the OTC Bulletin Board or any registered national
stock exchange on which the Common Stock is then listed, or if there is no such price on such date, then the closing bid price
on such exchange or quotation system on the date nearest preceding such date, or (b) if the Common Stock is not listed then on
the OTC Bulletin Board or any registered national stock exchange, the last closing bid price for a share of Common Stock in the
over-the-counter market, as reported by the OTC Bulletin Board or by Pink OTC Markets Inc. or similar organization or agency succeeding
to its functions of reporting prices) at the close of business on such date, or (c) if the Common Stock is not then reported by
the OTC Bulletin Board or by Pink OTC Markets Inc. (or similar organization or agency succeeding to its functions of reporting
prices), then the average of the “Pink Sheet” quotes for the five (5) Trading Days preceding such date of determination,
or (d) if the Common Stock is not then publicly traded the fair market value of a share of Common Stock as determined by the Board.

 

(f)
“Person” means an individual, a limited liability
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government
or any department or agency thereof.

 

(g)
“Principal Market” means the OTC Bulletin Board.

 

(h)
“Trading Day” means any day on which the Common
Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock,
then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that “Trading
Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than
4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during
the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder.

 

[Signature
Page Follows]

 

    	11

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set out above.

 

	 	BARFRESH
    FOOD GROUP Inc.
	 	 
	 	By:	 
	 	Name:	Riccardo
    Delle Coste
	 	Title:	Chief
    Executive Officer

 

    	 

    	 

    

  

EXHIBIT
A

 

EXERCISE
NOTICE

 

BARFRESH
FOOD GROUP Inc.

 

The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”)
of Barfresh Food Group Inc., a Delaware corporation (the “Company”), evidenced by Placement Agent Warrant to
Purchase Common Stock No. _______ (the “Warrant”). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant.

 

1.
Payment of Exercise Price. The Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the
Company in accordance with the terms of the Warrant.

 

2.
Delivery of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________
Warrant Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, to the following
address:

 

_______________________

 

_______________________

 

_______________________

 

_______________________

 

	Date:	 	 	 
	 	 	 	Registered
    Holder
	 	 	 	 
	 	 	 	By:	 
	 	 	 	Name:	 
	 	 	 	Title:	 

 

    	 

    	 

    

  

EXHIBIT
B

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares
of Common Stock in accordance with the Transfer Agent Instructions dated ______________, from the Company and acknowledged and
agreed to by _______________.

 

	Date:	 	 	BARFRESH
    FOOD GROUP Inc.
	 	 	 	 
	 	 	 	By:	 
	 	 	 	Name:	 
	 	 	 	Title:WARRANT
TO PURCHASE COMMON STOCK

 

of

 

Barfresh
Food Group Inc.

 

Void
after September 6, 2016

  

	Warrant
    No. 2013-CN_	Date
    of Issuance: September 6, 2013

 

This
certifies that, for value received, ____________________________, or its registered assigns (the “Holder”)
is entitled, subject to the terms set forth below, to purchase from Barfresh Food Group Inc. (the “Company”),
a Delaware corporation, _____________ (______) (being an amount equal to 100% x the “Principal Amount” of the related
Senior Subordinated Promissory Note issued pursuant to the Purchase Agreement – as defined below –, divided by the
Exercise Price) shares of the Common Stock of the Company (the “Shares”), upon surrender hereof, at the principal
office of the Company referred to below and simultaneous payment therefor in lawful money of the United States or otherwise as
hereinafter provided, at the Exercise Price as set forth in Section 2 below. This warrant (the “Warrant”) is
issued pursuant to the “Senior Subordinated Convertible Promissory Note Purchase Agreement” dated as of August 29,
2012, among the Company and certain “Purchasers” named therein (the “Purchase Agreement”). The
number, character and Exercise Price of such shares of Common Stock (the “Common Stock”) are subject to adjustment
as provided below. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution
or exchange therefor as provided herein.

 

1.
Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole
or in part, during the term commencing on the Date of Issuance, and ending at the sooner of: (i) the sale, conveyance or disposal
of all or substantially all of the Company’s property, assets or business or the Company’s merger with or into or
consolidation with any other corporation, limited liability company or other entity (other than a wholly-owned subsidiary of the
Company) or any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power
of the Company is disposed of (the “Change of Control”), provided that (A) this Section 1(i) shall not
apply to a merger effected exclusively for the purpose of changing the domicile of the Company or to an equity financing in which
the Company is the surviving corporation, and (B) a majority of the number of shares for which the Warrants are exercisable vote
to approve the Change of Control, and (ii) 5:00 p.m., Eastern Time on the third anniversary of the Date of Issuance, and shall
be void thereafter. For the avoidance of doubt, the Warrants shall not automatically expire upon the closing of a Pubco Transaction
(as defined in the Company’s Amended and Restated Certificate of Incorporation) or a Qualified Initial Public Offering (as
defined in the Company’s Amended and Restated Certificate of Incorporation).

 

2.
Exercise Price. The Exercise Price per share of Common Stock at which this Warrant may be exercised shall be equal
to $0.25 per share as adjusted from time to time pursuant to Section 10 below (the “Exercise Price”). If the
Exercise Price is adjusted, then the number of Shares issuable pursuant to this Warrant shall be appropriately adjusted, using
the formula set forth in Section 1 hereof.

 

    	 

    	 

    

  

3.
Exercise of Warrant.

 

(a)
The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time, or from time to
time, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly completed and executed on behalf of the
Holder, at the office of the Company (or such other office or agency of the Company as it may designate by notice in writing to
the Holder at the address of the Holder appearing on the books of the Company), upon payment in cash or by check acceptable to
the Company.

 

(b)
Notwithstanding anything to the contrary set forth herein, upon exercise of this Warrant, the Holder may, at the Holder’s
election, either (i) exercise this Warrant by paying to the Company an amount equal to the aggregate Exercise Price of the Shares
being purchased or (ii) receive Shares equal to the value (as determined below) of this Warrant, or the portion thereof being
cancelled, in which event the Company shall issue to the Holder a number of Shares computed using the following formula:

 

	 	X
    =	Y(A-B)	 
	 	A	 

 

	 	Where:	X
    = the number of Shares to be issued to the Holder
	 	 	 
	 	 	Y
    = the total number of Shares for which this Warrant is being exercised
	 	 	 
	 	 	A
    = the Current Fair Market Value of one Share
	 	 	 
	 	 	B
    = the Exercise Price then in effect

 

As
used herein, Current Fair Market Value of one Share shall mean, as of any particular date: (a) the volume weighted average of
the closing sales prices of the Common Stock for such day on all domestic securities exchanges on which the Common Stock may at
the time be listed; (b) if there have been no sales of the Common Stock on any such exchange on any such day, the average of the
highest bid and lowest asked prices for the Common Stock on all such exchanges at the end of such day; (c) if on any such day
the Common Stock is not listed on a domestic securities exchange, the closing sales price of the Common Stock as quoted on the
OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association for such day; or (d) if there have been no
sales of the Common Stock on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association on such day,
the average of the highest bid and lowest asked prices for the Common Stock quoted on the OTC Bulletin Board, the Pink OTC Markets
or similar quotation system or association at the end of such day; in each case, averaged over twenty (20) consecutive Business
Days ending on the business day immediately prior to the day as of which “Current Fair Market Value” is being determined;
provided, that if the Common Stock is listed on any domestic securities exchange, the term “Business Day” as
used in this sentence means Business Days on which such exchange is open for trading. If at any time the Common Stock is not listed
on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association,
the “Current Fair Market Value” of the Common Stock shall be the fair market value per share as determined in good
faith by the Board of Directors of the Company, unless the Holder shall purchase such shares in conjunction with an underwritten
public offering of Common Stock pursuant to a registration statement filed under the Securities Act of 1933 as amended (the “Securities
Act”), in which case the Current Fair Market Value shall be the price at which the Common Stock is sold to the public
in such offering.

 

    	2

    	 

    

 

(c)
This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for
exercise as provided above, and the person entitled to receive the shares of Common Stock issuable upon such exercise shall be
treated for all purposes as the holder of record of such shares as of the close of business on such date. As promptly as practicable
on or after such date, the Company at its expense shall issue and deliver to the person or persons entitled to receive the same
a certificate or certificates for the number of shares issuable upon such exercise. In the event that this Warrant is exercised
in part, the Company at its expense will execute and deliver a new Warrant of like tenor exercisable for the number of shares
for which this Warrant may then be exercised.

 

4.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall
make a cash payment equal to the Exercise Price multiplied by such fraction.

 

5.
Replacement of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction,
or mutilation of this Warrant and, in the case of loss, theft, or destruction, on delivery of an indemnity agreement reasonably
satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant,
the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 

6.
Rights of Stockholders. Until the Holder exercises this Warrant and the Company issues the Holder Shares purchasable
upon the exercise hereof, as provided herein, The Holder shall not be entitled to vote or receive dividends or be deemed the holder
of Common Stock or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose,
nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a shareholder of the
Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof,
or to give or withhold consent or assert dissenter’s rights with respect to any corporate action (whether upon any recapitalization,
issuance of stock, reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger,
conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise.

 

    	3

    	 

    

 

7.
Transfer of Warrant.

 

(a)
Warrant Register. The Company will maintain a register (the “Warrant Register”) containing the names
and addresses of the Holder. The Holder may change his address as shown on the Warrant Register by written notice to the Company
requesting such change. Any notice or written communication required or permitted to be given to the Holder may be delivered or
given by mail to the Holder as shown on the Warrant Register and at the address shown on the Warrant Register. Until this Warrant
is transferred on the Warrant Register, the Company may treat the Holder as shown on the Warrant Register as the absolute owner
of this Warrant for all purposes, notwithstanding any notice to the contrary.

 

(b)
Warrant Agent. The Company may, by written notice to the Holder, appoint an agent for the purpose of maintaining the Warrant
Register referred to in Section 7(a) above, issuing the Common Stock or other securities then issuable upon the exercise of this
Warrant, exchanging this Warrant, replacing this Warrant, or any or all of the foregoing. Thereafter, any such registration, issuance,
exchange, or replacement, as the case may be, shall be made at the office of such agent.

 

(c)
Transferability and Non-negotiability of Warrant. This Warrant may not be transferred or assigned in whole or in part without
compliance with the terms of this Warrant and all applicable federal and state securities laws by the transferor and the transferee
(including the delivery of investment representation letters reasonably satisfactory to the Company, if such are requested by
the Company).

 

(d)
Compliance with Securities Laws.

 

(i)
The Holder understands that the Warrant and the Shares are characterized as “restricted securities” under the 1933
Act inasmuch as they are being acquired from the Company in a transaction not involving a public offering, and that under the
1933 Act and applicable regulations thereunder, such securities may be resold without registration under the 1933 Act only in
certain limited circumstances. In this connection, the Holder represents that it is familiar with SEC Rule 144, as presently in
effect, and understands the resale limitations imposed thereby and by the 1933 Act. The Holder understands that the Company is
under no obligation to register any of the securities sold hereunder except as provided in Section 11 hereof. The Holder
understands that no public market now exists for this Warrant or the Shares and that it is uncertain whether a public market will
ever exist for this Warrant or the Shares.

 

(ii)
This Warrant and all certificates for the Shares issued upon exercise hereof shall be stamped or imprinted with a legend in substantially
the following form (in addition to any legend required by state securities laws):

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE SHARES MAY NOT BE SOLD OR OFFERED
FOR SALE IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SHARES UNDER SUCH ACT, (B) A “NO ACTION”
LETTER OF THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO SUCH SALE OR OFFER OR (C) SATISFACTORY ASSURANCES TO THE CORPORATION
THAT REGISTRATION UNDER SUCH ACT IS NOT REQUIRED WITH RESPECT TO SUCH SALE OR OFFER.”

 

    	4

    	 

    

  

(e)
Disposition of the Holder's Rights.

 

(i)
Transferability. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal
office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
for the purchase of Warrant Shares without having a new Warrant issued.

 

(ii)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 7(e)(i), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial exercise date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.

 

(f)
Market Stand-Off.

 

(i)
In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration
statement filed under the 1933 Act, including the Company's initial public offering, the Holder shall not sell, make any short
sale of, loan, hypothecate, pledge, grant any option for the purchase of, or otherwise dispose or transfer for value or otherwise
agree to engage in any of the foregoing transactions with respect to, any shares of Common Stock to be issued upon exercise hereof,
without the prior written consent of the Company or its underwriters. Such restriction (the “Market Stand-Off”)
shall be in effect for such period of time from and after the effective date of the final prospectus for the offering as may be
requested by the Company or such underwriters. In no event, however, shall such period exceed one hundred eighty (180) days, and
the Market Stand-Off shall in all events terminate two (2) years after the effective date of the Company's initial public offering.

 

(ii)
The Holder shall be subject to the Market Stand-Off only if the officers and directors of the Company are also subject to similar
restrictions.

 

(iii)
Any new, substituted or additional securities which are by reason of any recapitalization or reorganization of the Company distributed
with respect to the shares of Common Stock to be issued upon exercise hereof shall be immediately subject to the Market standoff,
to the same extent the shares of Common Stock to be issued upon exercise hereof are at such time covered by such provisions.

 

    	5

    	 

    

 

(iv)
In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the shares of Common
Stock to be issued upon exercise hereof until the end of the applicable stand-off period.

 

(g)
Any entity to whom the Holder transfers any right to purchase the Shares pursuant to this Warrant or any of the Shares issuable
upon the exercise of such right shall become a “Holder” for purposes of this Section 7.

 

8.
Reservation of Stock. The Company covenants that during the term this Warrant is exercisable, the Company will reserve
from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of Common Stock upon the
exercise of this Warrant and, from time to time, will take all steps necessary to amend its Amended and Restated Certificate of
Incorporation (the “Certificate”) as the same may be amended from time to time to provide sufficient reserves
of shares of Common Stock issuable upon exercise of the Warrant. The Company further covenants that all shares that may be issued
upon the exercise of rights represented by this Warrant, upon exercise of the rights represented by this Warrant and payment of
the Exercise Price, all as set forth herein, will be free from all taxes, liens, and charges in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein). The Company agrees that its
issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates
to execute and issue the necessary certificates for shares of Common Stock upon the exercise of this Warrant.

 

9.
Amendments.

 

(a)
Any term of the Warrants, including this Warrant, may be amended, and any waiver of any term of the Warrants may be granted, with
the written consent of the Company and the holders of Warrants exercisable for at least a majority of the shares of Common Stock
for which all Warrants are exercisable. Any amendment or waiver effected in accordance with this Section 9 shall be binding upon
the Holder and each future holder of the Warrant and the Company, notwithstanding the fact that the Holder or such future holder
did not consent to such amendment or waiver.

 

(b)
No waivers of or exceptions to any term, condition or provision of the Warrants, in any one or more instances, shall be deemed
to be, or construed as, a further or continuing waiver of any such term, condition or provision.

 

10.
Adjustments. The Exercise Price and the number of shares purchasable hereunder are subject to adjustment from time
to time as follows:

 

(a)
Reclassification, etc. If the Company at any time while this Warrant, or any portion thereof, remains outstanding and unexpired
shall, by reclassification of securities or otherwise, change any of the securities as to which purchase rights under this Warrant
exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent
the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect
to the securities which were subject to the purchase rights under this Warrant immediately prior to such reclassification or other
change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this
Section 10.

 

    	6

    	 

    

  

(b)
Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant, or any portion thereof, remains
outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist,
into a different number of securities of the same class, the Exercise Price for such securities shall be proportionately decreased
in the case of a split or subdivision or proportionately increased in the case of a combination.

 

(c)
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 10, the
Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish
to each holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon
which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of any such holder,
furnish or cause to be furnished to such holder a like certificate setting forth: (i) such adjustments and readjustments; (ii)
the Exercise Price at the time in effect; and (iii) the number of shares and the amount, if any, of other property which at the
time would be received upon the exercise of the Warrant.

 

13.
Miscellaneous.

 

(a)
Additional Undertaking. The Holder hereby agrees to take whatever additional action and execute whatever additional documents
the Company may deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed
on either the Holder or the shares of Common Stock issued upon exercise hereof pursuant to the provisions of this Warrant.

 

(b)
Governing Law. This Warrant shall be governed by, and construed in accordance with, the laws of the State of New York without
resort to that State's conflict-of-laws rules.

 

(c)
Successors and Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company
and its successors and assigns and upon the Holder, the Holder's permitted assigns and the legal representatives, heirs and legatees
of the Holder's estate, whether or not any such person shall have become a party to this Warrant and have agreed in writing to
join herein and be bound by the terms hereof.

 

(d)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.

 

    	7

    	 

    

  

(e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.

 

(f)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

(g)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the
Company or by creditors of the Company.

 

(h)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(Signatures
appear on the following page.)

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, Barfresh Food Group Inc. has caused this Warrant to be executed by its officer thereunto duly authorized.

 

Dated
as of September 6, 2013.

 

	 	BARFRESH
    FOOD GROUP INC.
	 	 	 
	 	By:	 
	 	Name:	Arnold
    Tinter
	 	Title:	Chief
    Financial Officer

 

    	9

    	 

    

 

NOTICE
OF EXERCISE

 

	To:	Barfresh Food Group Inc.

 

(1)
The undersigned hereby elects to purchase ____________ shares of Common Stock of Barfresh Food Group Inc., pursuant to the terms
of the attached Warrant.

 

	 	[  ]	Such
    exercise is made pursuant to Section 1(a) and the undersigned herewith makes payment of the Warrant Price for such shares
    in full in the amount of $___________.
	 	 	 
	 	[  ]	Such
    exercise is made pursuant to Section 1(b) and no cash is being paid herewith.

 

(2)
In exercising this Warrant, the undersigned hereby confirms and acknowledges that the shares of Common Stock have not been registered
under the Securities Act of 1933, as amended (the “1933 Act”), and are restricted securities under the 1933
Act and that the undersigned will not offer, sell, or otherwise dispose of any such shares of Common Stock except under circumstances
that will not result in a violation of the 1933 Act or any state securities laws.

 

(3)
Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such
other name as is specified below:

 

	 	Name	 
	 	 	 
	 	Name	 

 

(4)
Please issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersigned or in such other
name as is specified below:

 

	 	 	 	Name	 
	 	 	 	 	 
	 	 	 	Name	 
	 	 	 	 	 
	Date:	 	 	Signature:	 

 

    	10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]